Sort by
Refine Your Search
-
Country
-
Employer
- Indiana University
- Nanyang Technological University
- National University of Singapore
- UCL;
- City of Hope
- Cold Spring Harbor Laboratory
- Drexel University
- Florida Atlantic University
- Harvard University
- Max Planck Institute of Biochemistry, Martinsried
- Oden Institute for Computational Engineering and Sciences
- Queen's University Belfast
- University of Bergen
- University of California
- University of Colorado
- University of Maryland, Baltimore
- University of Michigan
- Zintellect
- Łukasiewicz PORT
- 9 more »
- « less
-
Field
-
. The successful candidate will take a leading role in materials synthesis and physicochemical characterisation, contribute to the development of calcination and powder engineering processes for downstream
-
develops biomaterial and chemistry-based approaches to manipulate dendritic cell function and downstream adaptive immune responses. Current projects include engineering tolerogenic dendritic cells
-
phenotype-genotype associations, plus downstream statistical analyses Train, fine-tune, and validate deep learning models on multi-omics and imaging data to predict clinical outcomes (e.g., relapse, therapy
-
of the lab is to characterize the role of nuclear pore complex machinery in mediating HIV-1 nuclear entry and subsequent downstream process that leads to productive viral gene integration. The goal
-
assays. Identify key downstream alternative splicing or expression changes as potential therapeutic targets, and develop appropriate ASOs to restore normal expression. Analyze and interpret experimental
-
for applications. Documented hands-on experience with isolation, quality assessment and preparation of single-cell and/or nuclei suspensions from complex biological material for downstream single-cell or single
-
characterize the role of nuclear pore complex machinery in mediating HIV-1 nuclear entry and subsequent downstream process that leads to productive viral gene integration. The goal of this position is to work
-
receptor coactivators, chromatin remodeling factors, and their downstream target genes in the development and progression of prostate cancer and breast cancer using cell culture systems, animal models, and
-
humane endpoints. Collect blood, tumors, and other tissues; perform or coordinate necropsy and tissue processing; and support downstream histologic, molecular, and pharmacodynamic/target-engagement
-
models for graphs. As part of Karsten Borgwardt's Department of Machine Learning and Systems Biology, these methodological advances will provide the foundation for a broad range of downstream analyses